跳至主要内容
临床试验/ISRCTN22214747
ISRCTN22214747已完成不适用

The effect of acupuncture versus mosapride citrate tablet versus routine health care in improving spontaneous bowel movements, stool consistency and straining during defecation in patients with constipation after ischemic stroke: a single-centre randomised controlled trial

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University0 个研究点目标入组 120 人开始时间: 2015年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosed with ischemic stroke according to the diagnostic criteria specified by the World Health Organization (WHO)
  • 2. With symptoms of constipation according to the Rome III functional constipation criteria
  • 3. 2 weeks to 6 months after stroke onset
  • 4. Aged between 30 and 75 years old, either gender
  • 5. The Glasgow Coma Scale (GCS) score = 7 and the National Institute of Health Stroke Scale (NIHSS) = 21, which indicates that participants are conscious and without dysfunctions in comprehension
  • 6. With no previous medical history of constipation before stroke onset and the symptoms of constipation present at least 2 weeks continuously after stroke
  • 7. No use of gastrointestinal drugs 1 week before randomisation (except for emergency drugs)
  • 8. No acupuncture treatment for constipation in the previous 2 weeks
  • 9. Volunteered to join the clinical trial and provided a signed informed consent form

排除标准

  • 1. Irritable bowel syndrome (IBS) and constipation secondary to organic diseases (for example, endocrine, metabolic or postoperative diseases) or drugs
  • 2. Participants with abdominal aneurysm, hepatosplenomegaly, serious cardiovascular, liver, kidney or psychiatric disease, or severe dystrophy who cannot cooperate to be examined or treated
  • 3. Pregnant women or women in lactation
  • 4. Blood coagulation disorders, or administration of anticoagulant agents such as warfarin and heparin (participants treated with antiplatelet treatment such as asprin or clopidogrel as secondary prevention of cerebral infarction are eligible)

研究者

发起方
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

相似试验